ATE264333T1 - Medikamente, die derivate der phosphorigensäure als aktiven inhaltsstoff enthalten - Google Patents

Medikamente, die derivate der phosphorigensäure als aktiven inhaltsstoff enthalten

Info

Publication number
ATE264333T1
ATE264333T1 AT00904097T AT00904097T ATE264333T1 AT E264333 T1 ATE264333 T1 AT E264333T1 AT 00904097 T AT00904097 T AT 00904097T AT 00904097 T AT00904097 T AT 00904097T AT E264333 T1 ATE264333 T1 AT E264333T1
Authority
AT
Austria
Prior art keywords
phosphorigenic
acid
disease
general formula
active ingredients
Prior art date
Application number
AT00904097T
Other languages
English (en)
Inventor
Toshiaki Matsui
Nagashige Ohmawari
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Application granted granted Critical
Publication of ATE264333T1 publication Critical patent/ATE264333T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/094—Esters of phosphoric acids with arylalkanols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
AT00904097T 1999-02-23 2000-02-22 Medikamente, die derivate der phosphorigensäure als aktiven inhaltsstoff enthalten ATE264333T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP4484099 1999-02-23
JP28310499 1999-10-04
PCT/JP2000/001005 WO2000050429A1 (fr) 1999-02-23 2000-02-22 Medicaments dont les principes actifs sont des derives d'acide phosphorique

Publications (1)

Publication Number Publication Date
ATE264333T1 true ATE264333T1 (de) 2004-04-15

Family

ID=26384807

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00904097T ATE264333T1 (de) 1999-02-23 2000-02-22 Medikamente, die derivate der phosphorigensäure als aktiven inhaltsstoff enthalten

Country Status (9)

Country Link
US (1) US6495533B1 (de)
EP (1) EP1156054B1 (de)
JP (1) JP4614031B2 (de)
KR (1) KR20010102360A (de)
AT (1) ATE264333T1 (de)
AU (1) AU2577100A (de)
DE (1) DE60009871T2 (de)
ES (1) ES2218119T3 (de)
WO (1) WO2000050429A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0416639A (pt) * 2003-11-19 2007-01-16 Metabasis Therapeutics Inc tiromiméticos contendo fósforo
WO2005080406A2 (en) * 2003-12-19 2005-09-01 Jerini Ag Compounds for the inhibition of undesired cell proliferation and use thereof
EP1750722A4 (de) * 2004-05-06 2010-03-10 Univ Virginia Neue lysophosphatidsäure-rezeptorselektive antagonisten
JP2008542301A (ja) 2005-05-26 2008-11-27 メタバシス・セラピューティクス・インコーポレイテッド 脂肪性肝疾患の処置のための甲状腺ホルモン様薬剤
US11202789B2 (en) 2016-11-21 2021-12-21 Viking Therapeutics, Inc. Method of treating glycogen storage disease
US11707472B2 (en) 2017-06-05 2023-07-25 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis
CN108484667A (zh) * 2018-03-21 2018-09-04 江苏正大清江制药有限公司 一种新化合物磷酯酰3-羟基丙腈的合成工艺
MX2020009843A (es) 2018-03-22 2020-12-11 Viking Therapeutics Inc Formas cristalinas y metodos de produccion de formas cristalinas de un compuesto.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ287284A (en) * 1994-06-06 1998-10-28 Warner Lambert Co N-[2-(phenyl(substituted)ethylamino)-1-(indolylmethyl)-1-methyl -2-oxoethyl] carbamic acid ester derivatives, medicaments and intermediates
US6368604B1 (en) * 1997-09-26 2002-04-09 University Of Maryland Biotechnology Institute Non-pyrogenic derivatives of lipid A

Also Published As

Publication number Publication date
US6495533B1 (en) 2002-12-17
EP1156054A4 (de) 2002-04-17
AU2577100A (en) 2000-09-14
WO2000050429A1 (fr) 2000-08-31
DE60009871D1 (de) 2004-05-19
JP4614031B2 (ja) 2011-01-19
EP1156054B1 (de) 2004-04-14
ES2218119T3 (es) 2004-11-16
DE60009871T2 (de) 2005-03-17
EP1156054A1 (de) 2001-11-21
KR20010102360A (ko) 2001-11-15

Similar Documents

Publication Publication Date Title
DE60003025T2 (de) Arylsulfonyle als faktor xa inhibitoren
JP4510372B2 (ja) アシルフェニル尿素誘導体、その製造方法及び医薬としてのその使用
BR9915985A (pt) 2-cianopirrolidinas n-substituìdas
IT1213132B (it) Agente antibroncopneumopatico.
CH657610A5 (de) 1-sulfo-2-oxoazetidin-derivate, ihre herstellung und sie enthaltende pharmazeutische praeparate.
YU70901A (sh) Derivati 1,4-benzotiazepin-1,1 dioksida zamenjeni radikalima šećera, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena
PT1004578E (pt) Derivados hidroxamida do acido 5-oxo-pirrolidino-2-carboxilico
HU199810B (en) Process for producing new aminomethyl-oxo-oxazolidinyl derivatives and pharmaceutical compositions comprising same
ATE264333T1 (de) Medikamente, die derivate der phosphorigensäure als aktiven inhaltsstoff enthalten
SE8605063D0 (sv) Derivatives of cyclohexane
IL165181A (en) Use of substituted cyanopyrrolidines for the manufacture of medicaments for treating hyperlipidemia and associated diseases
ES2218122T3 (es) Uso de sistemas de 2-amino-tiazol policiclicos para la preparacion de medicamentos para la profilaxis o tratamiento de la obesidad.
HU207522B (en) Process for producing esters of antibacterial cepheme-derivatives and pharmaceutical compositions containing them
ZA200206184B (en) Novel pyrazine derivatives or salts thereof, and pharmaceutical composition containing the same.
US4001420A (en) Thiazolyl benzoic acid compounds
JPS62138492A (ja) 新規化合物、その製法及びそれを含む医薬組成物
ES2100177T3 (es) Compuestos de cefalosporina y su produccion.
FR2361396A1 (fr) Derives d'acides 5-(2-furoyl)-, 5-(2-thenoyl)-, 5-(3-furoyl et 5-(3-thenoyl)-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrole-1 carboxyliques et leur procede de preparation
CA1190921A (en) 6-AMINOALKYLPENICILLANIC ACID 1,1-DIOXIDES AND DERIVATIVES AS .beta.-LACTAMASE INHIBITORS
US4406895A (en) Base-substituted anthranilic acids, a process for their preparation and their use
HU189866B (en) Process for producing new acylamino-phenyl-esters of thiazolidine-carboxylic acid
JP3639326B2 (ja) 新規なアコニチン型化合物及び鎮痛・抗炎症剤
US3864495A (en) Sulphonamides compositions and method for treating edema
JPS58188865A (ja) 新規ベンズイミダゾ−ル誘導体
Vaughan Jr et al. Antihistamine Agents. II. Furan Derivatives

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties